Online Patient Attitudes Toward Cutaneous Immune-Related Adverse Events Attributed to Nivolumab and Pembrolizumab: Sentiment Analysis.
Camille M PowersAndrew K YangHannah VermaJeremy N OrloffAustin J PiontkowskiNicholas GulatiPublished in: JMIR dermatology (2024)